The DOI matches its Crossref record; 70 of the 74 references it cites were found in a registry or an index; 20 of the 36 sources its claims cite were checked for support.
Acceptance and Commitment Therapy for people living with motor neuron disease: an uncontrolled feasibility study
Open accessAbstract
Background: Motor neuron disease (MND) is a fatal, progressive neurodegenerative disease that causes progressive weakening and wasting of limb, bulbar, thoracic and abdominal muscles. Clear evidence-based guidance on how psychological distress should be managed in people living with MND (plwMND) is lacking. Acceptance and Commitment Therapy (ACT) is a form of psychological therapy that may be particularly suitable for this population. However, to the authors' knowledge, no study to date has evaluated ACT for plwMND. Consequently, the primary aim of this uncontrolled feasibility study was to examine the feasibility and acceptability of ACT for improving the psychological health of plwMND. Methods: PlwMND aged ≥ 18 years were recruited from 10 UK MND Care Centres/Clinics. Participants received up to 8 one-to-one ACT sessions, developed specifically for plwMND, plus usual care. Co-primary feasibility and acceptability outcomes were uptake (≥ 80% of the target sample [N = 28] recruited) and initial engagement with the intervention (≥ 70% completing ≥ 2 sessions). Secondary outcomes included measures of quality of life, anxiety, depression, disease-related functioning, health status and psychological flexibility in plwMND and quality of life and burden in caregivers. Outcomes were assessed at baseline and 6 months. Results: Both a priori indicators of success were met: 29 plwMND (104%) were recruited and 76% (22/29) attended ≥ 2 sessions. Attrition at 6-months was higher than anticipated (8/29, 28%), but only two dropouts were due to lack of acceptability of the intervention. Acceptability was further supported by good satisfaction with therapy and session attendance. Data were possibly suggestive of small improvements in anxiety and psychological quality of life from baseline to 6 months in plwMND, despite a small but expected deterioration in disease-related functioning and health status. Conclusions: There was good evidence of acceptability and feasibility. Limitations included the lack of a control group and small sample size, which complicate interpretation of findings. A fully powered RCT to evaluate the clinical and cost-effectiveness of ACT for plwMND is underway. Trial registration: The study was pre-registered with the ISRCTN Registry (ISRCTN12655391). © 2023, The Author(s).
Overview
CoChat Summary
## TL;DR
This uncontrolled feasibility study found that adapted Acceptance and Commitment Therapy (ACT) was feasible and acceptable for people living with motor neuron disease (plwMND), with recruitment and early engagement meeting the pre-specified targets. The authors observed descriptive signs of small improvements in anxiety and psychological quality of life, but the lack of a control group and small sample size limit interpretation.
## Key findings
- The study met both a priori feasibility targets: 29/28 (104%) of the target sample were recruited, and 22/29 (76%) completed at least 2 ACT sessions.
- Acceptability was high: at 6 months, 79% (15/19) rated therapy as satisfactory and 100% (19/19) rated therapists as satisfactory on the STTS-R; 79% (15/19) said therapy made things somewhat or a lot better.
- Attrition at 6 months was 8/29 (28%); only 2/29 (7%) dropouts were due to dissatisfaction with the intervention.
- Descriptively, outcomes suggested small improvements in anxiety and psychological quality of life, while disease-related functioning and health status worsened as expected; reliable improvement in anxiety and psychological quality of life was seen in 3 participants (17%), and reliable deterioration in disease-related functioning was seen in 9 (43%).
## Methods
- Design: Pre-registered uncontrolled feasibility study in 10 UK MND Care Centres/Clinics (ISRCTN12655391).
- Sample and intervention: Adults with MND (plwMND) aged ≥18 years; participants received up to 8 one-to-one ACT sessions plus usual multidisciplinary care. Caregivers could attend up to three key sessions and also completed outcome measures.
- Analysis: No formal statistical hypothesis testing; outcomes were summarized descriptively, with change scores, Cohen’s d effect sizes, and Reliable Change Index calculations for paired baseline and 6-month data.
## Limitations
- The paper states that major limitations were the lack of a control group and small sample size, which complicate interpretation.
- The authors also note limited generalisability because most participants self-identified as White/White British, and the sample may not represent all plwMND since only 12% and 15% were in the clinical range for depression and anxiety at baseline, respectively.
- Evident from the text: follow-up was only 6 months, so durability beyond that point is unknown; participants needing gastrostomy feeding or non-invasive ventilation were excluded, so applicability to more advanced disease is unclear.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
11 Valid · 2 Not valid · 10 Not checked · 41 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Previous systematic reviews of psychological interventions to reduce psychological distress and improve psychological wellbeing in plwMND have highlighted limited research of varying quality [19, 20].”
§ Acceptance and Commitment Therapy for people living with motor neuron disease: an uncontrolled feasibility study > Background
What the sources say
- Not checked — no full text of the sourcecites [19] Gould RL, Coulson MC, Brown RG, Goldstein LH, Al-Chalabi A, Howard RJ. Psychotherapy and pharmacotherapy interventions to reduce distress or improve well-being in people with amyotrophic lateral sclerosis: A systematic review. Amyotroph Lateral Scler Front Degener. 2015;16(5–6):293–302. source
- Supportedcites [20] Zarotti N, Mayberry E, Ovaska-Stafford N, Eccles F, Simpson J. Psychological interventions for people with motor neuron disease: a scoping review. Amyotroph Lateral Scler Front Degener. 2021;22(1–2):1–11. source
The Discussion reports that the review found only ten studies of psychological interventions for people with MND, just three of them RCTs; the others were mainly quasi-experimental or uncontrolled. The Clinical implications and future directions section also identifies methodological weaknesses, supporting the claim that the research was limited and of varying quality. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Acceptance and Commitment Therapy (ACT) may be particularly suitable for people with life-limiting illnesses and disabling long-term conditions such as MND, muscle disorders, brain injury and chronic pain [5, 23–25].”
§ Acceptance and Commitment Therapy for people living with motor neuron disease: an uncontrolled feasibility study > Background
What the sources say
- Supportedcites [5] Weeks KR, Gould RL, Mcdermott C, Lynch J, Goldstein LH, Graham CD, et al. Needs and preferences for psychological interventions of people with motor neuron disease. Amyotroph Lateral Scler Front Degener. 2019;20(7–8):521–31. source
In “Implications for psychological interventions” (page not specified), the paper identifies ACT as potentially beneficial for people living with chronic or life-limiting conditions. Its conclusions also say ACT could be acceptable for people with MND if adapted to their needs. The other conditions in the citing sentence are accompanied by additional citations. (LLM, conf=0.87)
- Supportedcites [23] Rose MR, Graham CD, O'Connell N, Vari C, Edwards V, Taylor E, et al. A randomised controlled trial of acceptance and commitment therapy for improving quality of life in people with muscle diseases. Psychol Med. 2023;53(8):3511–24. source
The Introduction (page not provided) says ACT is often considered particularly suited to improving quality of life in chronic diseases. This trial supplies the muscle-disorder example: its Abstract Conclusions (page not provided) report improved quality of life in patients with muscle diseases. The other conditions appear in a sentence supported by multiple citations and are not attributed specifically to this trial. (LLM, conf=0.89)
- Partly supportedcites [24] Kangas M, McDonald S. Is it time to act? The potential of acceptance and commitment therapy for psychological problems following acquired brain injury. Neuropsychol Rehabil. 2011;21(2):250–76. sourceExperimental — accuracy not yet measured
The Evidence base for ACT interventions section reports benefits for chronic pain and discusses ACT’s potential for people with acquired brain injury. The Future directions section narrows its recommendation to distressed people recovering from mild to moderate brain injury; the cited passages do not address MND or muscle disorders. No page numbers are provided in our copy. (LLM, conf=0.86)
- Partly supportedcites [25] McCracken LM, Yu L, Vowles KE. New generation psychological treatments in chronic pain. BMJ. 2022;28:e057212. sourceExperimental — accuracy not yet measured
The Practical implications section reports that ACT benefits the average patient with chronic pain, and the included-studies table lists trials involving fibromyalgia and mild brain injury with chronic pain. But that section says the evidence is not strong or consistent enough to determine who is best suited to ACT. The paper does not establish particular suitability for the full range of life-limiting illnesses and conditions named, including MND. (LLM, conf=0.89)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In support of the latter interpretations, these results are consistent with a previous RCT of meditation training compared to usual care in plwMND [21].”
§ Acceptance and Commitment Therapy for people living with motor neuron disease: an uncontrolled feasibility study > Discussion
What the sources say
- Supportedcites [21] Pagnini F, Marconi A, Tagliaferri A, Manzoni GM, Gatto R, Fabiani V, et al. Meditation training for people with amyotrophic lateral sclerosis: a randomized clinical trial. Eur J Neurol. 2017;24(4):578–86. source
The Results section says patients with ALS were randomly assigned to meditation training or usual care. The Procedures section confirms that the experimental group received an eight-week ALS-specific meditation programme while controls received usual care. The citing authors’ assessment that their results are consistent with this trial is their own interpretation. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A similar pattern of stabilisation of quality of life, anxiety and depression in the treatment group compared to deterioration in the control group was recently reported in a small non-randomised controlled trial of empathy-based supportive counselling for people with ALS [62].”
§ Acceptance and Commitment Therapy for people living with motor neuron disease: an uncontrolled feasibility study > Discussion
What the sources say
- Supportedcites [62] Palmieri A, Kleinbub JR, Pagnini F, Sorarù G, Cipolletta S. Empathy-based supportive treatment in amyotrophic lateral sclerosis: A pragmatic study. Am J Clin Hypn. 2021;63(3):202–16. source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Although this might indicate that the intervention resulted in little change in ACT core processes, both the construct and discriminant validity of the AAQ-II have been questioned [64–66].”
§ Acceptance and Commitment Therapy for people living with motor neuron disease: an uncontrolled feasibility study > Discussion
What the sources say
- Supportedcites [64] Wolgast M. What Does the Acceptance and Action Questionnaire (AAQ-II) Really Measure? Behav Ther. 2014;45(6):831–9. source
The Discussion (p. 7) explicitly calls the AAQ-II’s discriminant validity highly questionable. It also questions whether the measure captures the intended psychological process rather than psychological distress, and whether it is appropriate for clinical research (pp. 7–8), supporting the claim about construct validity. (LLM, conf=0.91)
- Supportedcites [65] Tyndall I, Waldeck D, Pancani L, Whelan R, Roche B, Dawson DL. The Acceptance and Action Questionnaire-II (AAQ-II) as a measure of experiential avoidance: Concerns over discriminant validity. J Context Behav Sci. 2019;12:278–84. source
The Discussion (p. 13) describes the AAQ-II’s construct validity as challenging. The conclusion (p. 18) says the AAQ-II loses some discriminant validity because it appears to assess something between experiential avoidance and distress. Together, these passages support the claim that both aspects of its validity have been questioned. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [66] Rogge RD, Daks JS, Dubler BA, Saint KJ. It’s all about the process: Examining the convergent validity, conceptual coverage, unique predictive validity, and clinical utility of ACT process measures. J Context Behav Sci. 2019;14:90–102. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
22 more claims
Create a free account to see all 64 claims and to verify the 5 references still open.
- Probably not a substantial claim. 11
- It may state two separate claims as one. 29
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“We also demonstrated potential signals of efficacy, with respect to small improvements in psychological quality of life and anxiety.”
The cited source says what the claim attributes to it.
In the citing paper
“We showed that ACT, adapted for the specific needs of people with motor neuron disease, 17 was both acceptable to patients and feasible to deliver in an uncontrolled feasibility study. 18”
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139 · cited 1×
“Secondary patient-reported outcome measures at baseline and 6 months were the McGill Quality of Life Questionnaire-Revised (MQOL-R) [41], Hospital Anxiety and Depression Scale modified for plwMND (mHADS) [42, 43], Acceptance and Action Questionnaire-II (AAQ-II) [44], EQ-5D-5L (including the Visual Analogue Scale [VAS]…”
MethodMcKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657 · cited 1×
“those in stages 4A or 4B of the King’s College London clinical staging system [32], as these are markers of significantly reduced life expectancy and more advanced disease stage (and hence an indicator that participants might not survive the duration of the study); (2) Diagnosis of dementia using standard diagnostic g…”
MethodDepression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
Hoffmann, T. C., Glasziou, P. P., Boutron, I., Milne, R., Perera, R., Moher, D., Altman, D. G., Barbour, V., Macdonald, H., Johnston, M., et al. (2014) · BMJ · doi:10.1136/bmj.g1687 · Cited by 10,548
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795 · cited 1×
“Secondary patient-reported outcome measures at baseline and 6 months were the McGill Quality of Life Questionnaire-Revised (MQOL-R) [41], Hospital Anxiety and Depression Scale modified for plwMND (mHADS) [42, 43], Acceptance and Action Questionnaire-II (AAQ-II) [44], EQ-5D-5L (including the Visual Analogue Scale [VAS]…”
MethodThe validity of the Hospital Anxiety and Depression Scale
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00296-3 · Cited by 9,779
Jacobson, N. S., & Truax, P. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.12 · Cited by 7,770 · cited 1×
“Finally, Reliable Change Index (RCI) scores [52] were calculated in order to examine whether any changes in outcome measures across time were reliable (i.”
MethodRelatives of the Impaired Elderly: Correlates of Feelings of Burden
Zarit, S. H., Reever, K. E., & Bach-Peterson, J. (1980) · The Gerontologist · doi:10.1093/geront/20.6.649 · Cited by 5,810 · cited 8×
“EQ-VAS EQ-Visual Analogue Scale, ES Effect size, mHADS Hospital Anxiety and Depression Scale modified for plwMND such that one depression item and one anxiety item were not scored, as previously recommended [43], MQOL-R McGill Quality of Life Questionnaire-Revised, SD Standard deviation, STTS-R Satisfaction with Thera…”
MethodInfluentialEl Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433 · cited 1×
“Eligible plwMND were aged ≥ 18 years with a diagnosis of definite, laboratorysupported probable or probable familial or sporadic Amyotrophic Lateral Sclerosis (ALS, which is diagnostically synonymous with MND [30]) using the World Federation of Neurology’s El Escorial criteria [31].”
MethodBond, F. W., Hayes, S. C., Baer, R. A., Carpenter, K. M., Guenole, N., Orcutt, H. K., Waltz, T., & Zettle, R. D. (2011) · Behavior Therapy · doi:10.1016/j.beth.2011.03.007 · Cited by 3,950 · cited 8×
“Although this might indicate that the intervention resulted in little change in ACT core processes, both the construct and discriminant validity of the AAQ-II have been questioned [64–66].”
MethodInfluential
Research works printed but not linked: 1
- Castle HV. Using Cognitive Interviewing to assess the Validity of Acceptance and Commitment Therapy (ACT) Questionnaires in individuals with Chronic Pain [D.Clin.Psychol thesis]. University of Leeds; 2019. Available from: https://etheses.whiterose.ac.uk/25119/1/Castle_HV_DClinPsychol_2019.pdf.pdf.
Cited by
Gould, R. L., McDermott, C. J., Thompson, B. J., Rawlinson, C. V., Bursnall, M., Bradburn, M., Kumar, P., Turton, E. J., White, D. A., Serfaty, M. A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00533-6 · Cited by 38
“18 We also demonstrated potential signals of efficacy, with respect to small improvements in psychological quality of life and anxiety.”
Self-citationHoxhaj, P., Hastings, N. E., Kachhadia, M. P., Gupta, R., Sindhu, U., Durve, S. A., Azam, A., Vinueza, M. J. A., Bhuvan, Win, S. H., et al. (2023) · Cureus · doi:10.7759/cureus.45489 · Cited by 34
“Mental health of ALS patients and family caregivers may also be taken into account, and psychotherapy strategies can diminish anxiety and depression and aid with the regrettable outcome of the disease [35-37].”
BackgroundGould, R. L., Thompson, B. J., Rawlinson, C., Kumar, P., White, D., Serfaty, M. A., Graham, C. D., McCracken, L. M., Bursnall, M., Bradburn, M., et al. (2022) · BMC Neurology · doi:10.1186/s12883-022-02950-5 · Cited by 16
Self-citationAdvances in symptom management and in monitoring disease progression in motor neuron disease
Hobson, E., & McDermott, C. J. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.04.004 · Cited by 6
Self-citationRawlinson, C. V., Gould, R. L., McDermott, C. J., Thompson, B. T., Weeks, K., Gossage-Worrall, R., Serfaty, M. A., Graham, C. D., McCracken, L. M., White, D. A., et al. (2024) · The Cognitive Behaviour Therapist · doi:10.1017/s1754470x24000333 · Cited by 5
“An uncontrolled feasibility study showed that ACT adapted for the specific needs of plwMND appears to be feasible to deliver and acceptable to this population, as indicated by good session attendance and high satisfaction rates, respectively (Gould et al ., 2023).”
Self-citation
Metadata
- Authors
- Gould, R. L., Rawlinson, C., Thompson, B., Weeks, K., Gossage-Worrall, R., Cantrill, H., Serfaty, M. A., Graham, C. D., McCracken, L. M., White, D., Howard, R. J., Bursnall, M., Bradburn, M., Al-Chalabi, A., Orrell, R., Chhetri, S. K., Noad, R., Radunovic, A., Williams, T., Young, C. A., Dick, D., Lawrence, V., Goldstein, L. H., Young, T., Ealing, J., McLeod, H., Williams, N., Weatherly, H., Cave, R., Chiwera, T., Pagnini, F., Cooper, C., Shaw, P. J., McDermott, C. J., and the COMMEND Collaboration Group, Burns, A., Dancyger, C., Dee, A., Henley, S., Howell, M., Kishita, N., Makin, S., Mayberry, E., Oliver, M., Richards, A., Robinson, E., & Tallentire, L.
- Affiliations
- University College London (GB)
- University of Sheffield (GB)
- University of Strathclyde (GB)
- Uppsala University (SE)
- UCL Queen Square Institute of Neurology (GB)
- Lancashire Teaching Hospitals NHS Foundation Trust (GB)
- Derriford Hospital (GB)
- Walton Centre (GB)
- Norfolk and Norwich University Hospital (GB)
- King's College London (GB)
- Salford Royal NHS Foundation Trust (GB)
- University of Glasgow (GB)
- University of Oxford (GB)
- University of York (GB)
- Università Cattolica del Sacro Cuore (IT)
- Corresponding author
- Gould, Rebecca L.
- ORCID
- Gould, Rebecca L.
- Rawlinson, Charlotte
- Thompson, Ben
- Weeks, Kirsty
- Gossage-Worrall, Rebecca
- Serfaty, Marc A.
- Graham, Christopher D.
- McCracken, Lance M.
- White, David
- Howard, Robert J.
- Bradburn, Mike
- Chhetri, Suresh K.
- Noad, Rupert
- Young, Carolyn A.
- Lawrence, Vanessa
- Goldstein, Laura H.
- Young, Tracey
- McLeod, Hamish
- Williams, Nicola
- Weatherly, Helen
- Cave, Richard
- Chiwera, Theresa
- Pagnini, Francesco
- Cooper, Cindy
- Shaw, Pamela J.
- McDermott, Christopher J.
- Henley, Susie
- Kishita, Naoko
- Makin, Selina
- Mayberry, Emily
- Richards, Alexandra
- Robinson, Emma
- Tallentire, Liz
- Venue
- Pilot and Feasibility Studies
- Published
- 2023-07-07
- Volume
- 9
- Issue
- 1
- Pages
- 116-116
- ISSN
- 2055-5784 (ISSN-L)
- PMC
- PMC10327371
- OpenAlex
- W4383534888
- Cited by
- 10
- References
- 74
- Citations by year
- 2026: 2 · 2024: 6 · 2023: 1
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Pilot and Feasibility Studies (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Portal (King's College London) (publishedVersion, other-oa)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, other-oa)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion, other-oa)
- Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (acceptedVersion, other-oa)
- Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Health Technology Assessment Programme (16/81/01)
- Motor Neurone Disease Association (Gould/Jul17/936-794)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- motor neuron disease, acceptance and commitment therapy, psychological distress, feasibility, acceptability, psychological flexibility, quality of life, anxiety, depression, caregiver burden, health status
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acceptance and Commitment Therapy for people living with motor neuron disease: an uncontrolled feasibility study. https://app.cochat.ai/papers/10.1186/s40814-023-01354-7
- The paper
- Gould, R. L., Rawlinson, C., Thompson, B., Weeks, K., Gossage-Worrall, R., Cantrill, H., Serfaty, M. A., Graham, C. D., McCracken, L. M., White, D., Howard, R. J., Bursnall, M., Bradburn, M., Al-Chalabi, A., Orrell, R., Chhetri, S. K., Noad, R., Radunovic, A., Williams, T., . . . Tallentire, L. (2023). Acceptance and Commitment Therapy for people living with motor neuron disease: an uncontrolled feasibility study. Pilot and Feasibility Studies. https://doi.org/10.1186/s40814-023-01354-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
